» Articles » PMID: 22308487

Glut1-mediated Glucose Transport Regulates HIV Infection

Abstract

Cell cycle entry is commonly considered to positively regulate HIV-1 infection of CD4 T cells, raising the question as to how quiescent lymphocytes, representing a large portion of the viral reservoir, are infected in vivo. Factors such as the homeostatic cytokine IL-7 have been shown to render quiescent T cells permissive to HIV-1 infection, presumably by transiently stimulating their entry into the cell cycle. However, we show here that at physiological oxygen (O(2)) levels (2-5% O(2) tension in lymphoid organs), IL-7 stimulation generates an environment permissive to HIV-1 infection, despite a significantly attenuated level of cell cycle entry. We identify the IL-7-induced increase in Glut1 expression, resulting in augmented glucose uptake, as a key factor in rendering these T lymphocytes susceptible to HIV-1 infection. HIV-1 infection of human T cells is abrogated either by impairment of Glut1 signal transduction or by siRNA-mediated Glut1 down-regulation. Consistent with this, we show that the susceptibility of human thymocyte subsets to HIV-1 infection correlates with Glut1 expression; single-round infection is markedly higher in the Glut1-expressing double-positive thymocyte population than in any of the Glut1-negative subsets. Thus, our studies reveal the Glut1-mediated metabolic pathway as a critical regulator of HIV-1 infection in human CD4 T cells and thymocytes.

Citing Articles

HIV-1 Elite Controllers Are Characterized by Elevated Levels of CD69-Expressing Natural Killer Cells.

Batohi N, Shalekoff S, Shalekoff S, Martinson N, Ebrahim O, Tiemessen C J Acquir Immune Defic Syndr. 2024; 97(5):522-532.

PMID: 39219024 PMC: 11540281. DOI: 10.1097/QAI.0000000000003518.


High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells.

De La Torre Tarazona E, Passaes C, Moreno S, Saez-Cirion A, Alcami J Sci Rep. 2024; 14(1):13980.

PMID: 38886484 PMC: 11183235. DOI: 10.1038/s41598-024-64902-y.


A novel humanized mouse model for HIV and tuberculosis co-infection studies.

Bohorquez J, Adduri S, Ansari D, John S, Florence J, Adejare O Front Immunol. 2024; 15:1395018.

PMID: 38799434 PMC: 11116656. DOI: 10.3389/fimmu.2024.1395018.


Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.

Das A, Martinez-Ruiz G, Bouladoux N, Stacy A, Moraly J, Vega-Sendino M Immunity. 2024; 57(5):1019-1036.e9.

PMID: 38677292 PMC: 11096055. DOI: 10.1016/j.immuni.2024.04.001.


ATF4 Signaling in HIV-1 Infection: Viral Subversion of a Stress Response Transcription Factor.

Corne A, Adolphe F, Estaquier J, Gaumer S, Corsi J Biology (Basel). 2024; 13(3).

PMID: 38534416 PMC: 10968437. DOI: 10.3390/biology13030146.


References
1.
Manganaro L, Lusic M, Gutierrez M, Cereseto A, Del Sal G, Giacca M . Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. Nat Med. 2010; 16(3):329-33. DOI: 10.1038/nm.2102. View

2.
Rosenzweig M, Clark D, Gaulton G . Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS. 1993; 7(12):1601-5. DOI: 10.1097/00002030-199312000-00009. View

3.
Rathmell J, Elstrom R, Cinalli R, Thompson C . Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol. 2003; 33(8):2223-32. DOI: 10.1002/eji.200324048. View

4.
Sportes C, Babb R, Krumlauf M, Hakim F, Steinberg S, Chow C . Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res. 2010; 16(2):727-35. PMC: 2808195. DOI: 10.1158/1078-0432.CCR-09-1303. View

5.
Montel-Hagen A, Sitbon M, Taylor N . Erythroid glucose transporters. Curr Opin Hematol. 2009; 16(3):165-72. DOI: 10.1097/MOH.0b013e328329905c. View